Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy

Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a devastating disease caused by mutations in the dystrophin gene that result in the complete absence of dystrophin protein. We have shown previously that recombinant mouse Galectin-1 treatment improves physiological and histological outcome measures in the mdx mo...

Full description

Bibliographic Details
Main Authors: Ryan D. Wuebbles, Vivian Cruz, Pam Van Ry, Pamela Barraza-Flores, Paul D. Brewer, Peter Jones, Dean J. Burkin
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Molecular Therapy: Methods & Clinical Development
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050119300075

Internet

http://www.sciencedirect.com/science/article/pii/S2329050119300075

Similar Items